日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL)

Capivasertib (AZD5363) 是一种强效口服泛 AKT 抑制剂,用于治疗复发或难治性 B 细胞非霍奇金淋巴瘤患者的疗效和安全性 (CAPITAL)

Hodson, Daniel J; Shouse, Geoffrey; Shin, Ho-Jin; Salar, Antonio; Bobillo, Sabela; Ribrag, Vincent; Macpherson, Nicol A; Cordoba, Raul; Kim, Jin Seok; Guidez, Stephanie; Herrera, Alex F; Morschhauser, Franck; Colton, Dachelle; Izuzquiza, Macarena; Sambamurthy, Nisha; Munugalavadla, Veerendra; Vicente, Sergio; Gorgun, Gullu; Chen, Robert; Younes, Anas; Wang, Michael L

Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis

利用基于血浆核磁共振代谢组学的诊断时代谢组学对弥漫性大B细胞淋巴瘤患者进行风险分层

Montagne, Aurélie; Bertho, Gildas; Papastergiou, Thomas; Chartier, Loïc; Ricci, Romain; Jardin, Fabrice; Ghesquières, Hervé; Rossi, Cédric; Morschhauser, Franck; Haioun, Corinne; Ribrag, Vincent; Feugier, Pierre; Brisou, Gabriel; Oberic, Lucie; Gaulard, Philippe; Giraud, Nicolas; Bennani, Younès; Thieblemont, Catherine; Baud, Véronique

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA-EU MCL 网络套细胞淋巴瘤诊断和治疗指南

Jerkeman, Mats; Aurer, Igor; Campo, Elias; Cheah, Chan Y; Clark, Jonathan; Doorduijn, Jeanette; Eyre, Toby A; Fehr, Martin; Giné, Eva; Gomes da Silva, Maria; Klener, Pavel; Ladetto, Marco; Ribrag, Vincent; Shpilberg, Ofer; Walewski, Jan; Dreyling, Martin

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

抗PD-1疗法治疗结外NK/T细胞淋巴瘤的疗效:来自LYSA研究的匹配队列分析

Marouf, Amira; Chaubard, Sammara; Liévin, Raphaël; Michot, Jean-Marie; Molinari, Nicolas; Rossignol, Julien; Cavalieri, Doriane; Golfier, Camille; Allangba, Olivier; Philippe, Laure; Tessoulin, Benoît; Chauchet, Adrien; Deau, Bénédicte; Oberic, Lucie; Vargaftig, Jacques; Moignet, Aline; Clavert, Aline; Dulery, Rémy; Brisou, Gabriel; Tardy, Stéphanie; Fataccioli, Virginie; Houot, Roch; Casasnovas, René O; Thieblemont, Catherine; Ghesquières, Hervé; Carras, Sylvain; Le Gouill, Steven; Cartron, Guillaume; Ribrag, Vincent; Cheminant, Morgane; Marçais, Ambroise; Suarez, Felipe; Marabelle, Aurélien; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; De Leval, Laurence; Lemonnier, François; Bachy, Emmanuel; Chevret, Sylvie; Hermine, Olivier; Couronné, Lucile; Jaccard, Arnaud

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study

LYSA 研究通过对 1280 例参与临床试验的套细胞淋巴瘤患者进行分析,验证了 POD24 作为套细胞淋巴瘤早期预后不良的可靠临床指标的有效性。

Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy; Geisler, Christian H; Kluin-Nelemans, Hanneke C; Thieblemont, Catherine; Morschhauser, Franck; Lemonnier, François; Safar, Violaine; Tessoulin, Benoît; Oberic, Lucie; Damaj, Ghandi; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier; Houot, Roch; Klapper, Wolfram; Burroni, Barbara; Pott, Christiane; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin; Le Gouill, Steven; Hermine, Olivier; Cheminant, Morgane

A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas

Acimtamig (AFM13)治疗CD30阳性、复发或难治性外周T细胞淋巴瘤患者的II期研究

Kim, Won Seog; Shortt, Jake; Zinzani, Pier Luigi; Mikhailova, Natalia; Radeski, Dejan; Ribrag, Vincent; Domingo Domenech, Eva; Sawas, Ahmed; Alexis, Karenza; Emig, Michael; Elbadri, Riham; Hajela, Pallavi; Ravenstijn, Paulien; Pinto, Sheena; Garcia, Linta; Overesch, Andre; Pietzko, Kerstin; Horwitz, Steven

Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

tazemetostat联合R-CHOP方案治疗新诊断为弥漫性大B细胞淋巴瘤的老年患者的疗效:LYSA研究的EpiRCHOP II期研究结果

Sarkozy, Clémentine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cédric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stéphanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma

4个疗程后的中期PET检查可预测组织分子学确诊的原发性纵隔B细胞淋巴瘤的预后

Camus, Vincent; Molina, Thierry; Desmots, Fabienne; Blanc-Durand, Paul; Kanoun, Salim; Moslemi, Amine; Ruminy, Philippe; Le Gouill, Steven; Ghesquières, Hervé; Oberic, Lucie; Morschhauser, Franck; Tilly, Hervé; Ribrag, Vincent; Houot, Roch; Thieblemont, Catherine; Maisonneuve, Hervé; Claves, Fabien; Bouabdallah, Krimo; Haioun, Corinne; Damaj, Gandhi Laurent; Fornecker, Luc-Matthieu; Noel, Robin; Feugier, Pierre; Sibon, David; Cartron, Guillaume; Bonnet, Christophe; Bernard, Wivine; Kraeber-Bodéré, Françoise; Bodet-Milin, Caroline; Jais, Jean-Philippe; Brière, Josette; Rossi, Cedric; Elsensohn, Mad-Hélénie; Chartier, Loïc; Itti, Emmanuel; Jardin, Fabrice; Fest, Thierry

Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network

年轻套细胞淋巴瘤患者的条件生存率:欧洲套细胞淋巴瘤网络一项随机III期试验的结果

Jiang, Linmiao; Dreyling, Martin; Hermine, Olivier; Mansmann, Ulrich; Walewski, Jan; Ribrag, Vincent; Thieblemont, Catherine; Pott, Christiane; Bachy, Emmanuel; Feugier, Pierre; Hübel, Kai; Schumacher, Martin; Hoster, Eva

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

在针对复发或难治性非霍奇金淋巴瘤和B细胞慢性淋巴细胞白血病患者的I期首次人体临床试验中,使用crenigacestat (LY3039478)抑制Notch通路。

Michot, Jean-Marie; Balogh, Zsofia; Brown, Jennifer R; Ribrag, Vincent; Hollebecque, Antoine; Bahleda, Rastislav; Quivoron, Cyril; Ammari, Samy; Scoazec, Jean-Yves; Benhadji, Karim A; Massard, Christophe